Climb Bio Income Statement (2020-2026) | CLYM

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
5.48M5.99M6.88M8.26M8.77M4.26M4.93M5.72M3.69M2.88M3.13M1.09M1.05M6.24M5.96M17.33M6.58M9.07M13.74M9.37M
Selling, General & Administrative (Quarter)
2.91M3.39M3.82M4.87M4.93M4.49M4.63M17.72M3.03M2.12M2.00M1.91M3.67M5.49M4.95M5.69M4.10M5.82M5.56M5.84M
Other Operating Expenses (Quarter)
0.32M0.02M0.06M0.09M0.90M51.66M
Operating Expenses (Quarter)
8.71M9.38M10.70M13.13M13.70M8.75M9.55M23.44M6.71M5.00M5.12M3.00M56.37M11.73M10.91M23.02M10.68M14.89M19.30M15.21M
Operating Income (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M
EBIT (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M
Non-operating items
Non Operating Investment Income (Quarter)
0.02M-0.10M-0.40M-0.08M0.02M0.22M0.26M0.06M0.02M0.01M0.00M0.20M-0.18M0.26M0.03M0.15M-0.03M-0.28M
Interest & Investment Income (Quarter)
0.15M0.38M0.76M0.90M1.11M1.26M1.35M1.34M1.49M2.79M2.52M2.29M2.17M2.04M1.83M1.51M
Other Non Operating Income (Quarter)
-0.01M-0.23M0.16M-0.16M-0.90M-0.93M1.79M1.15M1.49M1.03M1.48M1.31M-0.00M0.05M8.11M-0.05M-0.16M-0.03M-0.05M-0.03M
Non Operating Income (Quarter)
-0.01M-0.23M0.16M-0.07M-0.90M-0.93M1.79M1.15M1.49M1.03M1.48M1.31M1.48M2.84M2.50M2.24M2.01M2.00M1.78M1.49M
Net income details
EBT (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Profit After Tax (Quarter)
-8.72M-9.62M-10.54M-13.20M-14.60M-9.68M-7.76M-22.29M-5.22M-3.97M-3.64M-1.70M-54.89M-8.89M-8.42M-20.78M-8.67M-12.89M-17.52M-13.72M
Income from Non-Controlling Interests (Quarter)
-9.63M-10.65M-13.60M
Income from Continuing Operations (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Consolidated Net Income (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Income towards Parent Company (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Preferred Dividend Payments (Quarter)
2.14M1.32M
Net Income towards Common Stockholders (Quarter)
-10.86M-10.94M-10.54M-13.20M-14.60M-9.68M-7.76M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M
Additional items
EPS (Basic) (Quarter)
-3.11-0.701.25-0.50-0.37-0.37-0.29-0.84-0.19-0.15-0.13-0.06-1.81-0.130.04-0.31-0.13-0.19-0.25-0.20
EPS (Weighted Average and Diluted) (Quarter)
-3.11-0.701.25-0.50-0.37-0.37-0.29-0.84-0.19-0.15-0.13-0.06-1.81-0.130.04-0.31-0.13-0.19-0.25-0.20
Shares Outstanding (Weighted Average) (Quarter)
3.47M7.55M12.26M26.24M26.27M26.34M26.31M26.49M26.84M26.80M26.99M27.64M28.99M67.01M48.16M67.46M67.59M67.69M67.81M68.21M
Shares Outstanding (Diluted Average) (Quarter)
3.47M15.59M12.26M26.24M26.27M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M41.76M48.16M67.46M67.52M68.00M67.81M68.21M
EBITDA (Quarter)
-8.72M-9.63M-10.65M-13.60M-14.68M-9.66M-7.54M-22.03M-5.16M-3.94M-3.63M-1.70M-54.89M-8.69M-8.59M-20.52M-8.63M-12.74M-17.55M-14.00M
Shares Outstanding (Quarter)
3.49M26.20M26.24M26.24M26.33M26.35M26.39M26.82M26.88M27.37M27.63M27.66M66.74M67.22M67.26M67.58M67.76M68.18M47.77M47.77M